Sign in
Taking people in United StatesNo phase

Tests meal replacement products for weight and blood sugar in low-income adults

Studies meal replacements for weight loss and blood sugar in adults with obesity or diabetes.

Key facts

Who runs it
Massachusetts General Hospital
Where
Boston, United StatesSee the site
Trial code
Registry title
Medically Intensive Nutrition Therapy Program for Obesity and Diabetes in a Low-income Population
Status
Recruiting
People taking part
20 people, planned
Started
28 Mar 2023
Planned end
10 Nov 2026
Type of study
Observational
Treatments tested
  • Bariatrix Meal Replacement Products
Record updated
24 December 2025

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for low-income adults with overweight or obesity and raised blood sugar or diabetes, to test whether meal replacements help with weight loss and blood sugar.

Age
18 to 65 years
Sex
All sexes can join.
Disease stage
BMI of 27 kg/m^2 or higher. HgA1C of 5.7 percent or higher, or fasting glucose of 100mg/dL (5.6 mmol/L) or higher, within the previous 6 months. HbA1c must be below 10 percent.
Earlier treatment
People cannot be using diabetes drugs other than metformin, or approved weight-loss drugs, now or in the next 3 months.
Biomarker or test result
HgA1C of 5.7 percent or higher, or fasting glucose of 100mg/dL (5.6 mmol/L) or higher, within the previous 6 months.

Main reasons for not taking part

  • Family income above 400 percent of the 2022 federal poverty level
  • HbA1c of 10 percent or higher
  • Plans for bariatric surgery within the next 6 months
  • Weight loss of more than 5 kg (11 lb) in the previous 3 months
  • Pregnant, breastfeeding, or considering pregnancy within the next 6 months

The registry criteria, word for word

Show all 13 criteriaShow less

Who can take part

  • Age 18-65
  • Body mass index (BMI) greater than or equal to 27 kg/m\^2
  • HgA1C greater than or equal to 5.7 percent or fasting glucose greater than or equal to 100mg/dL within the previous 6 months
  • Low-income as defined by having a family income at or below 400 percent of the federal poverty level guidelines for 2022

Who cannot take part

  • Current use of antihyperglycemic agents (other than metformin) or approved anti- obesity medications or plans to start such regimens over the 3 months post-study enrollment
  • Plans to pursue bariatric surgery over the 6 months post-study enrollment
  • Weight loss of greater than 5 kg within the previous 3 months
  • Current active eating disorder, with the exception of binge eating disorder
  • Severe active psychiatric disease or significant cognitive impairment deemed by investigator likely to impede adherence to piloted intervention
  • HbA1c greater than or equal to 10 percent
  • Active illicit substance abuse
  • Pregnant, breastfeeding, or considering pregnancy within the next 6 months
  • Current participation in another clinical research trial deemed by investigator to conflict with current study

Check if you might fit

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 65 years old?

Where in United States

  • Massachusetts General HospitalBoston, United StatesContact: Chika V Anekwe, MDTaking people

About the trial

What the trial wants to find out

This study is being done to better understand whether meal replacements can be an effective tool for weight loss and treatment of elevated blood sugars in people with obesity/overweight and diabetes/pre-diabetes who have a low income.

The group in the trial

  • Adults with overweight/obesity and pre-diabetes/diabetes and low income

    Adults with overweight or obesity and pre-diabetes or type 2 diabetes who earn a low income.

    Treatment: Bariatrix Meal Replacement Products

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Saves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Feasibility Study of an Intensive Nutrition Therapy Program for Improvement of Obesity and Diabetes in a Low-income Population
Plain-language title
Tests meal replacement products for weight and blood sugar in low-income adultsGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 12 November 2026.
Fit questions
Built from NCT05799222, who can take part
Record updated
24 December 2025